India approved different vaccines under emergency use authorization but distribution of vaccines and vaccination of huge population was a challenging task. We attempted to review the vaccination program from an ethics perspective. METHODS :The core ethical principles of healthcare and other tenets put ...
NEW DELHI, Jan. 27 (Xinhua) -- India's national drugs regulator the Drug Controller General of India (DCGI) on Thursday gave nod to market authorization of two COVID-19 vaccines, Covaxin and Covishield, under certain conditions. An expert body, the Central Drug Standard Control Organisation (...
were taken up by the DCGI. In a major development, on January 3, 2021, DCGI approved two COVID-19 vaccines for restricted emergency use in the country20. Bharat Biotech’s Covid-19 vaccine Covaxin has been recommended for conditional approval (i.e., to be administered under clinical trial...
As of August 2022, there are 220 vaccine candidates in phase I to phase III clinical trials and 40 vaccines approved in at least one country worldwide, of which 11 vaccines have been granted Emergency Use Listing (EUL) by the World Health Organization (WHO) [2,3,5]. These 11 vaccines ...
The vaccines that are available in India are Covishield (AstraZeneca's vaccine manufactured by Serum Institute of India), Covaxin (manufactured by Bharat Biotech Limited), and Russian vaccine Sputnik-V which will be supplied by Dr Reddy's Laboratories. Another vaccine approved in the country is ...
The UK has approved a COVID vaccine — here’s what scientists now want to knowThe Pfizer–BioNTech vaccine has passed safety and efficacy tests — but researchers still have many questions about how this and other vaccines will perform as they’re rolled out to millions of people. ...
General of India has permitted emergency use of Covid vaccine Sputnik V with certain conditions, clearing the way for a third vaccine in addition to Covishield and Covaxin. Besides, the government on Tuesday also fast-tracked emergency approval for other jabs. Here is what the vaccines are all...
A safe and effective vaccine is a critical tool to control the COVID-19 pandemic. As of 25 June 2021, 23 vaccines had advanced to Stage 3 clinical trials1and more than a dozen had been approved in multiple countries2. The BNT162b vaccine from Pfizer–BioNTech, for example, has been app...
Covaxin has been approved for emergency use in India, buthas been mired in controversy due to criticism that there was a lack of transparency in its approval, and also because it hasn't published enough efficacy data. India vaccines suitable for developing world ...
In total there are now more than 230 vaccine candidates, according to the World Health Organization, using an array of different techniques to trigger antibodies and virus-fighting cells to fend off infection. Several vaccines have already been approved for use or are seeking approval, and vaccinat...